NEWAMSTERDAM PHARMA COMPANY

Q3 2025 13F holders

CUSIP
N62509109
Type
Equity
Class
ORDINARY SHARES
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type